Status:

UNKNOWN

Blood Biomarker Discovery by Raman Spectroscopy in Acute Aortic Dissection

Lead Sponsor:

First Affiliated Hospital Xi'an Jiaotong University

Conditions:

Acute Aortic Dissection

Eligibility:

All Genders

18-90 years

Brief Summary

This study intends to collect about 500 cases of blood samples from acute aortic dissection (AAD) and other acute chest pain diseases (eg, AMI, PE, or angina).The investigators tend to detect Raman me...

Detailed Description

Sample Collection: Blood (serum and plasma) collection from all the selected subjects at admission will be performed following the collection tube manufacturer's instructions. Then the collected sampl...

Eligibility Criteria

Inclusion

  • Clinical diagnosis of AAD; Clinical diagnosis of AMI; Clinical diagnosis of PE; Clinical diagnosis of angina; Healthy participants; Provided written consent for the blood samples analysis; Age between 18 and 90 years.

Exclusion

  • Transfusion history (packed red blood cells, whole blood, or platelets) 10 days before the blood sample was taken; Aortic trauma; Pseudo aneurysm; History of heart failure; Renal dysfunction; Severe pulmonary diseases; Active cancer; Checkup after surgery.

Key Trial Info

Start Date :

December 1 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2022

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT05206032

Start Date

December 1 2021

End Date

December 31 2022

Last Update

January 25 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

First Affiliated Hospital of Xian JiaotongUniversity

Xi'an, Shaanxi, China, 710061